NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: C000000445

Registered date:05/07/2006

A randomized controlled trial by a parallel group design in a single institution to evaluate the effectiveness of oral adjuvant chemotherapy using uracil-tegafur to prevent recurrence after curative resection of hepatocellular carcinoma

Basic Information

Recruitment status Complete: follow-up complete
Health condition(s) or Problem(s) studiedCases with hepatocellular carcinoma, which is removed curatively and surgically
Date of first enrollment1997/08/01
Target sample size160
Countries of recruitmentJapan
Study typeInterventional
Intervention(s)Oral administration of uracil-tegafur (300mg/day) for 1 year after curative resection of hepatocellular carcinoma Only follow-up without any anti-cancer and anti-virus therapy after curative resection of hepatocellular carcinoma

Outcome(s)

Primary OutcomeRecurrence-free survival
Secondary OutcomeOverall survival

Key inclusion & exclusion criteria

Age minimum15years-old
Age maximum79years-old
GenderMale and Female
Include criteria
Exclude criteriaThe presence of clinically confirmed extrahepatic metastasis, macroscopic evidence of tumor thrombus in the inferior vena cava or the main portal vein, other previous or synchronous malignant disorders, and postoperative dysfunction of any organ

Related Information

Contact

public contact
Name Masatoshi Makuuchi
Address 7-3-1, Hongo, Bunkyo-ku, Tokyo, Japan Japan
Telephone 03-5800-8841
E-mail makuuchi-tky@umin.ac.jp
Affiliation Tokyo University Hospital Hepato-Biliary-Pancreatic Surgery Division
scientific contact
Name Masatoshi Makuuchi
Address 7-3-1, Hongo, Bunkyo-ku, Tokyo, Japan Japan
Telephone 03-5800-8841
E-mail
Affiliation Tokyo University Hospital Hepato-Biliary-Pancreatic Surgery Division